{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T07:08:58Z","timestamp":1776323338498,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s11912-021-01177-w","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T10:03:06Z","timestamp":1642759386000},"page":"69-76","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Active Surveillance of Thyroid Microcarcinomas: a Critical View"],"prefix":"10.1007","volume":"24","author":[{"given":"Claudio R.","family":"Cernea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leandro Luongo","family":"Matos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cec\u00edlia","family":"Eug\u00eanio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna Mattos","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmin Sa","family":"Cerqueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Kober N.","family":"Leite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe A. B.","family":"Vanderlei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorival","family":"de Carlucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato N.","family":"Gotoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fl\u00e1vio C.","family":"Hojaij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vergilius J. F.","family":"Ara\u00fajo-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"1177_CR1","first-page":"254","volume":"29","author":"T Kocher","year":"1883","unstructured":"Kocher T. Ueber Kropfexstirpation und ihre Folgen. Arch Klin Chir. 1883;29:254\u2013337.","journal-title":"Arch Klin Chir"},{"key":"1177_CR2","unstructured":"Kocher T. Concerning pathological manifestations in low-grade thyroid disease. The Nobel Prize website; 1909; Available from: http:\/\/nobelprize.org\/nobel_prizes\/medicine\/laureates\/1909\/kocher lecture.pdf."},{"key":"1177_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1089\/105072503321669875","volume":"13","author":"Y Ito","year":"2003","unstructured":"Ito Y, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid. 2003;13:381\u20137. https:\/\/doi.org\/10.1089\/105072503321669875.","journal-title":"Thyroid"},{"key":"1177_CR4","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/ncpendmet0428","volume":"3","author":"Y Ito","year":"2007","unstructured":"Ito Y, Miyauchi A. A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroid. Nat Clin Pract Endocrinol Metab. 2007;3:240\u20138. https:\/\/doi.org\/10.1038\/ncpendmet0428.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"1177_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00268-009-0303-0","volume":"34","author":"Y Ito","year":"2010","unstructured":"Ito Y, Miyauchi A, Inoue H, Fukushima M, Kihara M, Higashiyama T, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg. 2010;34:28\u201335. https:\/\/doi.org\/10.1007\/s00268-009-0303-0.","journal-title":"World J Surg"},{"key":"1177_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1089\/thy.2013.0367","volume":"24","author":"Y Ito","year":"2014","unstructured":"Ito Y, Miyauchi A, Kihara M, Higashiyama T, Kobayashi K, Miya A. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid. 2014;24:27\u201334. https:\/\/doi.org\/10.1089\/thy.2013.0367.","journal-title":"Thyroid"},{"key":"1177_CR7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1089\/thy.2020.0330","volume":"31","author":"I Sugitani","year":"2021","unstructured":"\u2022\u2022 Sugitani I, Ito Y, Takeuchi D, Nakayama H, Masaki C, Shindo H, et al. Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the Japan Association of Endocrine Surgery Task Force on management for papillary thyroid microcarcinoma. Thyroid. 2021;31:183\u201392. https:\/\/doi.org\/10.1089\/thy.2020.0330. (This very comprehensive manuscript, produced by the pioneer centers in AS, offers important considerations about the indication of AS in PTMC.)","journal-title":"Thyroid"},{"key":"1177_CR8","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1001\/jamaoto.2017.1442","volume":"143","author":"RM Tuttle","year":"2017","unstructured":"Tuttle RM, Fagin JA, Minkowitz G, Wong RJ, Roman B, Patel S, et al. Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance. JAMA Otolaryngol Head Neck Surg. 2017;143:1015\u201320. https:\/\/doi.org\/10.1001\/jamaoto.2017.1442.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"1177_CR9","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1089\/thy.2018.0263","volume":"28","author":"HS Oh","year":"2018","unstructured":"Oh HS, Ha J, Kim HI, Kim TH, Kim WG, Lim DJ, et al. Active surveillance of low-risk papillary thyroid microcarcinoma: a multi-center cohort study in Korea. Thyroid. 2018;28:1587\u201394. https:\/\/doi.org\/10.1089\/thy.2018.0263.","journal-title":"Thyroid"},{"key":"1177_CR10","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3803\/EnM.2018.33.2.278","volume":"33","author":"JH Moon","year":"2018","unstructured":"Moon JH, Kim JH, Lee EK, Lee KE, Kong SH, Kim YK, et al. Study protocol of multicenter prospective cohort study of active surveillance on papillary thyroid microcarcinoma (MAeSTro). Endocrinol Metab (Seoul). 2018;33:278\u201386. https:\/\/doi.org\/10.3803\/EnM.2018.33.2.278.","journal-title":"Endocrinol Metab (Seoul)"},{"key":"1177_CR11","doi-asserted-by":"publisher","first-page":"e172","DOI":"10.1210\/clinem\/dgz113","volume":"1","author":"E Molinaro","year":"2020","unstructured":"Molinaro E, Campopiano MC, Pieruzzi L, Matrone A, Agate L, Bottici V, et al. Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at a single Italian center. J Clin Endocrinol Metab. 2020;1:e172\u201380. https:\/\/doi.org\/10.1210\/clinem\/dgz113.","journal-title":"J Clin Endocrinol Metab"},{"key":"1177_CR12","doi-asserted-by":"publisher","first-page":"e020298","DOI":"10.1136\/bmjopen-2017-020298","volume":"12","author":"AM Sawka","year":"2018","unstructured":"Sawka AM, Ghai S, Tomlinson G, Rotstein L, Gilbert R, Gullane P, et al. A protocol for a Canadian prospective observational study of decision-making on active surveillance or surgery for low-risk papillary thyroid cancer. BMJ Open. 2018;12:e020298. https:\/\/doi.org\/10.1136\/bmjopen-2017-020298.","journal-title":"BMJ Open"},{"key":"1177_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.canep.2019.03.011","volume":"60","author":"R Reinke","year":"2019","unstructured":"Reinke R, Mathiesen JS, Larsen SR, Hahn CH, Pedersen HB, Bentzen J, et al. Incidental and non-incidental papillary thyroid microcarcinoma in Denmark 1996\u20132015: a national study on incidence, outcome and thoughts on active surveillance. Cancer Epidemiol. 2019;60:46\u201350. https:\/\/doi.org\/10.1016\/j.canep.2019.03.011.","journal-title":"Cancer Epidemiol"},{"key":"1177_CR14","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1089\/thy.2015.0313","volume":"26","author":"H Oda","year":"2016","unstructured":"Oda H, Miyauchi A, Ito Y, Yoshioka K, Nakayama A, Sasai H, et al. Incidences of unfavorable events in the management of low-risk papillary microcarcinoma of the thyroid by active surveillance versus immediate surgery. Thyroid. 2016;26:150\u20135. https:\/\/doi.org\/10.1089\/thy.2015.0313.","journal-title":"Thyroid"},{"key":"1177_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.surg.2018.07.045","volume":"165","author":"A Miyauchi","year":"2019","unstructured":"Miyauchi A, Kudo T, Ito Y, Oda H, Yamamoto M, Sasai H, et al. Natural history of papillary thyroid microcarcinoma: kinetic analyses on tumor volume during active surveillance and before presentation. Surgery. 2019;165:25\u201330. https:\/\/doi.org\/10.1016\/j.surg.2018.07.045.","journal-title":"Surgery"},{"key":"1177_CR16","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00268-015-3184-4","volume":"40","author":"Y Ito","year":"2016","unstructured":"Ito Y, Miyauchi A, Oda H, Kobayashi K, Kihara M, Miya A. Revisiting low-risk thyroid papillary microcarcinomas resected without observation: was immediate surgery necessary? World J Surg. 2016;40:523\u20138. https:\/\/doi.org\/10.1007\/s00268-015-3184-4.","journal-title":"World J Surg"},{"key":"1177_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1507\/endocrj.EJ15-0637","volume":"63","author":"Y Ito","year":"2016","unstructured":"Ito Y, Oda H, Miyauchi A. Insights and clinical questions about the active surveillance of low-risk papillary thyroid microcarcinomas. Endocr J. 2016;63:323\u20138. https:\/\/doi.org\/10.1507\/endocrj.EJ15-0637.","journal-title":"Endocr J"},{"key":"1177_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020.","journal-title":"Thyroid"},{"key":"1177_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/lio2.356","volume":"7","author":"S Lohia","year":"2020","unstructured":"\u2022 Lohia S, Hanson M, Tuttle RM, Morris LGT. Active surveillance for patients with very low-risk thyroid cancer. Laryngoscope Investig Otolaryngol. 2020;7:175\u201382. https:\/\/doi.org\/10.1002\/lio2.356. (This manuscript details the present experience of Memorial Sloan-Kettering Cancer Center with AS for PTMC.)","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"1177_CR20","doi-asserted-by":"publisher","unstructured":"Cibas ES, Ali SZ; NCI Thyroid FNA State of the Science Conference. The bethesda system for reporting thyroid cytopathology. Am J Clin Pathol 2009:132:658-65. https:\/\/doi.org\/10.1309\/AJCPPHLWMI3JV4LA.","DOI":"10.1309\/AJCPPHLWMI3JV4LA"},{"key":"1177_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1089\/thy.2018.0462","volume":"29","author":"T Sakai","year":"2019","unstructured":"Sakai T, Sugitani I, Ebina A, Fukuoka O, Toda K, Mitani H, et al. Active surveillance for T1bN0M0 papillary thyroid carcinoma. Thyroid. 2019;29:59\u201363. https:\/\/doi.org\/10.1089\/thy.2018.0462.","journal-title":"Thyroid"},{"issue":"1","key":"1177_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1089\/thy.2013.0367","volume":"24","author":"Y Ito","year":"2014","unstructured":"Ito Y, Miyauchi A, Kihara M, Higashiyama T, Kobayashi K, Miya A. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid. 2014;24(1):27\u201334. https:\/\/doi.org\/10.1089\/thy.2013.0367.","journal-title":"Thyroid"},{"key":"1177_CR23","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1089\/thy.2015.0429","volume":"26","author":"S Siddiqui","year":"2016","unstructured":"Siddiqui S, White MG, Antic T, Grogan RH, Angelos P, Kaplan EL, et al. Clinical and pathologic predictors of lymph node metastasis and recurrence in papillary thyroid microcarcinoma. Thyroid. 2016;26:807\u201315. https:\/\/doi.org\/10.1089\/thy.2015.0429.","journal-title":"Thyroid"},{"key":"1177_CR24","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3389\/fendo.2018.00736","volume":"14","author":"S Xue","year":"2018","unstructured":"\u2022\u2022 Xue S, Wang P, Hurst ZA, Chang YS, Chen G. Active surveillance for papillary thyroid microcarcinoma: challenges and prospects. Front Endocrinol (Lausanne). 2018;14:736. https:\/\/doi.org\/10.3389\/fendo.2018.00736. (A very comprehensive review of the benefits and limitations of AS for PTMC. The authors mention some promising perspectives, emphasizing the need to develop molecular analysis of PTMC with prognostic relevance at fine-needle aspiration biopsy cytology.)","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1177_CR25","doi-asserted-by":"publisher","first-page":"871","DOI":"10.2214\/AJR.09.2386","volume":"193","author":"JS Choi","year":"2009","unstructured":"Choi JS, Kim J, Kwak JY, Kim MJ, Chang HS, Kim EK. Preoperative staging of papillary thyroid carcinoma: comparison of ultrasound imaging and CT. AJR Am J Roentgenol. 2009;193:871\u20138. https:\/\/doi.org\/10.2214\/AJR.09.2386.","journal-title":"AJR Am J Roentgenol"},{"key":"1177_CR26","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/lary.21227","volume":"121","author":"HS Hwang","year":"2011","unstructured":"Hwang HS, Orloff LA. Efficacy of preoperative neck ultrasound in the detection of cervical lymph node metastasis from thyroid cancer. Laryngoscope. 2011;121:487\u201391. https:\/\/doi.org\/10.1002\/lary.21227.","journal-title":"Laryngoscope"},{"key":"1177_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/hed.23277","volume":"36","author":"D Lesnik","year":"2014","unstructured":"Lesnik D, Cunnane ME, Zurakowski D, Acar GO, Ecevit C, Mace A, et al. Papillary thyroid carcinoma nodal surgery directed by a preoperative radiographic map utilizing CT scan and ultrasound in all primary and reoperative patients. Head Neck. 2014;36:191\u2013202. https:\/\/doi.org\/10.1002\/hed.23277.","journal-title":"Head Neck"},{"key":"1177_CR28","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1089\/thy.2015.0176","volume":"25","author":"MT Khokhar","year":"2015","unstructured":"Khokhar MT, Day KM, Sangal RB, Ahmedli NN, Pisharodi LR, Beland MD, et al. Preoperative high-resolution ultrasound for the assessment of malignant central compartment lymph nodes in papillary thyroid cancer. Thyroid. 2015;25:1351\u20134. https:\/\/doi.org\/10.1089\/thy.2015.0176.","journal-title":"Thyroid"},{"key":"1177_CR29","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1089\/thy.2012.0563","volume":"23","author":"EJ Kuo","year":"2013","unstructured":"Kuo EJ, Goffredo P, Sosa JA, Roman SA. Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph-node metastases: a population-level analysis. Thyroid. 2013;23:1305\u201311. https:\/\/doi.org\/10.1089\/thy.2012.0563.","journal-title":"Thyroid"},{"key":"1177_CR30","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1007\/s00268-006-0837-3","volume":"31","author":"T Carling","year":"2007","unstructured":"Carling T, Ocal IT, Udelsman R. Special variants of differentiated thyroid cancer: does it alter the extent of surgery versus well-differentiated thyroid cancer? World J Surg. 2007;31:916\u201323. https:\/\/doi.org\/10.1007\/s00268-006-0837-3.","journal-title":"World J Surg"},{"issue":"7","key":"1177_CR31","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/hed.21494","volume":"33","author":"CE Silver","year":"2011","unstructured":"Silver CE, Owen RP, Rodrigo JP, Rinaldo A, Devaney KO, Ferlito A. Aggressive variants of papillary thyroid carcinoma. Head Neck. 2011;33(7):1052\u20139. https:\/\/doi.org\/10.1002\/hed.21494.","journal-title":"Head Neck"},{"key":"1177_CR32","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1530\/EJE-15-0254","volume":"173","author":"AU Bastos","year":"2015","unstructured":"Bastos AU, Oler G, Nozima BH, Moys\u00e9s RA, Cerutti JM. BRAF V600E and decreased NIS and TPO expression are associated with aggressiveness of a subgroup of papillary thyroid microcarcinoma. Eur J Endocrinol. 2015;173:525\u201340. https:\/\/doi.org\/10.1530\/EJE-15-0254.","journal-title":"Eur J Endocrinol"},{"key":"1177_CR33","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1530\/ERC-14-0531","volume":"22","author":"F Li","year":"2015","unstructured":"Li F, Chen G, Sheng C, Gusdon AM, Huang Y, Lv Z, et al. BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysis. Endocr Relat Cancer. 2015;22:159\u201368. https:\/\/doi.org\/10.1530\/ERC-14-0531.","journal-title":"Endocr Relat Cancer"},{"key":"1177_CR34","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1002\/jcb.25506","volume":"117","author":"D Li","year":"2016","unstructured":"Li D, Gao M, Li X, Xing M. Molecular aberrance in papillary thyroid microcarcinoma bearing high aggressiveness: identifying a \u201cTibetan mastiff dog\u201d from puppies. J Cell Biochem. 2016;117:1491\u20136. https:\/\/doi.org\/10.1002\/jcb.25506.","journal-title":"J Cell Biochem"},{"key":"1177_CR35","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1002\/cncr.26425","volume":"118","author":"LA Niemeier","year":"2012","unstructured":"Niemeier LA, Kuffner Akatsu H, Song C, Carty SE, et al. A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma. Cancer. 2012;118:2069\u201377. https:\/\/doi.org\/10.1002\/cncr.26425.","journal-title":"Cancer"},{"key":"1177_CR36","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1089\/thy.2016.0645","volume":"27","author":"T Yabuta","year":"2017","unstructured":"Yabuta T, Matsuse M, Hirokawa M, Yamashita S, Mitsutake N, Miyauchi A. TERT promoter mutations were not found in papillary thyroid microcarcinomas that showed disease progression on active surveillance. Thyroid. 2017;27:1206\u20137. https:\/\/doi.org\/10.1089\/thy.2016.0645.","journal-title":"Thyroid"},{"key":"1177_CR37","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1089\/thy.2017.0448","volume":"28","author":"Y Ito","year":"2018","unstructured":"Ito Y, Miyauchi A, Kudo T, Oda H, Yamamoto M, Sasai H, et al. Trends in the implementation of active surveillance for low-risk papillary thyroid microcarcinomas at Kuma Hospital: gradual increase and heterogeneity in the acceptance of this new management option. Thyroid. 2018;28:488\u201395. https:\/\/doi.org\/10.1089\/thy.2017.0448.","journal-title":"Thyroid"},{"key":"1177_CR38","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1089\/thy.2016.0483","volume":"27","author":"B Nickel","year":"2017","unstructured":"Nickel B, Brito JP, Barratt A, Jordan S, Moynihan R, McCaffery K. Clinicians\u2019 views on management and terminology for papillary thyroid microcarcinoma: a qualitative study. Thyroid. 2017;27:661\u201371. https:\/\/doi.org\/10.1089\/thy.2016.0483.","journal-title":"Thyroid"},{"key":"1177_CR39","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1089\/thy.2020.0694","volume":"31","author":"P Shih","year":"2021","unstructured":"Shih P, Nickel B, Degeling C, Thomas R, Brito JP, McLeod DSA, et al. Terminology change for small low-risk papillary thyroid cancer as a response to overtreatment: results from three australian community juries. Thyroid. 2021;31:1067\u201375. https:\/\/doi.org\/10.1089\/thy.2020.0694.","journal-title":"Thyroid"},{"key":"1177_CR40","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4699","volume":"23","author":"LJ Esserman","year":"2019","unstructured":"Esserman LJ, Varma M. Should we rename low risk cancers? BMJ. 2019;23: k4699. https:\/\/doi.org\/10.1136\/bmj.k4699.","journal-title":"BMJ"},{"key":"1177_CR41","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s12020-020-02566-0","volume":"72","author":"A Smulever","year":"2021","unstructured":"\u2022 Smulever A, Pitoia F. Active surveillance in small cytological indeterminate thyroid nodules: a call to common sense? Endocrine. 2021;72:505\u201312. https:\/\/doi.org\/10.1007\/s12020-020-02566-0. (The experience of the first South American group to recommend AS for PTMC.)","journal-title":"Endocrine"},{"key":"1177_CR42","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jss.2020.08.061","volume":"258","author":"R Pollack","year":"2021","unstructured":"\u2022\u2022 Pollack R, Mazeh H. Active surveillance of thyroid microcarcinoma-can this approach be safely implemented worldwide? J Surg Res. 2021;258:145\u201352. https:\/\/doi.org\/10.1016\/j.jss.2020.08.061. (A very important manuscript, with a critical appraisal of the difficulties for a universal acceptance of AS for PTMC.)","journal-title":"J Surg Res"},{"key":"1177_CR43","doi-asserted-by":"publisher","first-page":"454","DOI":"10.20945\/2359-3997000000181","volume":"63","author":"CR Cernea","year":"2019","unstructured":"Cernea CR. Active surveillance of thyroid microcarcinomas. Arch Endocrinol Metab. 2019;63:454\u20135. https:\/\/doi.org\/10.20945\/2359-3997000000181.","journal-title":"Arch Endocrinol Metab"},{"key":"1177_CR44","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.surg.2020.08.019","volume":"169","author":"MA Schumm","year":"2021","unstructured":"Schumm MA, Ohev-Shalom R, Nguyen DT, Kim J, Tseng CH, Zanocco KA. Measuring patient perceptions of surgeon communication performance in the treatment of thyroid nodules and thyroid cancer using the communication assessment tool. Surgery. 2021;169:282\u20138. https:\/\/doi.org\/10.1016\/j.surg.2020.08.019.","journal-title":"Surgery"},{"key":"1177_CR45","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/pon.4383","volume":"27","author":"TA D'Agostino","year":"2018","unstructured":"D\u2019Agostino TA, Shuk E, Maloney EK, Zeuren R, Tuttle RM, Bylund CL. Treatment decision making in early-stage papillary thyroid cancer. Psychooncology. 2018;27:61\u20138. https:\/\/doi.org\/10.1002\/pon.4383.","journal-title":"Psychooncology"},{"key":"1177_CR46","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12885-018-4152-9","volume":"18","author":"B Nickel","year":"2018","unstructured":"Nickel B, Brito JP, Moynihan R, Barratt A, Jordan S, McCaffery K. Patients\u2019 experiences of diagnosis and management of papillary thyroid microcarcinoma: a qualitative study. BMC Cancer. 2018;18:242. https:\/\/doi.org\/10.1186\/s12885-018-4152-9.","journal-title":"BMC Cancer"},{"key":"1177_CR47","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.surg.2019.05.078","volume":"167","author":"JF Lin","year":"2020","unstructured":"Lin JF, Jonker PKC, Cunich M, Sidhu SB, Delbridge LW, Glover AR, et al. Surgery alone for papillary thyroid microcarcinoma is less costly and more effective than long term active surveillance. Surgery. 2020;167:110\u20136. https:\/\/doi.org\/10.1016\/j.surg.2019.05.078.","journal-title":"Surgery"},{"key":"1177_CR48","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1001\/jamaoto.2015.2419","volume":"141","author":"BC Stack Jr","year":"2015","unstructured":"Stack BC Jr, Angelos P. The ethics of disclosure and counseling of patients with thyroid cancer. JAMA Otolaryngol Head Neck Surg. 2015;141:957\u20138. https:\/\/doi.org\/10.1001\/jamaoto.2015.2419.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"1177_CR49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/thy.2013.0659","volume":"24","author":"DS Ross","year":"2014","unstructured":"Ross DS, Tuttle RM. Observing micropapillary thyroid cancers. Thyroid. 2014;24:3\u20136. https:\/\/doi.org\/10.1089\/thy.2013.0659.","journal-title":"Thyroid"},{"key":"1177_CR50","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1001\/jama.2019.5350","volume":"321","author":"KA Zanocco","year":"2019","unstructured":"\u2022\u2022 Zanocco KA, Hershman JM, Leung AM. Active surveillance of low-risk thyroid cancer. JAMA. 2019;321:2020\u20131. https:\/\/doi.org\/10.1001\/jama.2019.5350. (The authors discuss the limitations for ample acceptance of AS for PTMC in routine daily practice, recommending that, initially, it should be restricted to specialized centers, in an IRB-approved prospective investigation.)","journal-title":"JAMA"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-021-01177-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11912-021-01177-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-021-01177-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T05:18:23Z","timestamp":1644470303000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11912-021-01177-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1177"],"URL":"https:\/\/doi.org\/10.1007\/s11912-021-01177-w","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"6 September 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}